Our findings demonstrate that CGREF1 exerts regulatory control over the activation level of the Wnt pathway by modulating GSK3β/β-catenin signal transduction within this pathway, thereby influencing the malignant proliferative behavior of osteosarcoma cells. The gene discussed is GSK3B; the disease is osteosarcoma.